IL-7, alone or synergizing with IL-1β or IL-23, can also increase IL-22 production in ILC3s via aryl hydrocarbon receptor (AhR) and STAT3, and eventually promote colitis-associated colon cancer progression [61]. Here, IL22 is linked to malignant colon neoplasm.